SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-004097
Filing Date
2008-01-23
Accepted
2008-01-23 16:16:56
Documents
5
Period of Report
2008-01-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-2315_18k.htm 8-K 48817
2 EX-1.1 a08-2315_1ex1d1.htm EX-1.1 198888
3 EX-4.4 a08-2315_1ex4d4.htm EX-4.4 732004
4 EX-99.1 a08-2315_1ex99d1.htm EX-99.1 5972
5 EX-99.2 a08-2315_1ex99d2.htm EX-99.2 9968
  Complete submission text file 0001104659-08-004097.txt   997411
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 08544765
SIC: 2834 Pharmaceutical Preparations